Stock Screener · Library
Dianthus Therapeutics, Inc. /DE/ financial statement history
Source-linked financial facts for Dianthus Therapeutics, Inc. /DE/ with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 189934000 | USD | 2023-03-23 | 2022 / FY | us-gaap:Assets | 10-K · 0000950170-23-009331 |
| As of 2022-12-31 | 83110000 | USD | 2024-03-21 | 2023 / FY | us-gaap:Assets | 10-K · 0000950170-24-034681 |
| As of 2023-12-31 | 179405000 | USD | 2025-03-11 | 2024 / FY | us-gaap:Assets | 10-K · 0000950170-25-037131 |
| As of 2024-12-31 | 374008000 | USD | 2026-03-09 | 2025 / FY | us-gaap:Assets | 10-K · 0001690585-26-000006 |
| As of 2025-12-31 | 530922000 | USD | 2026-03-09 | 2025 / FY | us-gaap:Assets | 10-K · 0001690585-26-000006 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 180693000 | USD | 2023-03-23 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-23-009331 |
| As of 2022-12-31 | 82033000 | USD | 2024-03-21 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-24-034681 |
| As of 2023-12-31 | 177451000 | USD | 2025-03-11 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-25-037131 |
| As of 2024-12-31 | 280904000 | USD | 2026-03-09 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001690585-26-000006 |
| As of 2025-12-31 | 409438000 | USD | 2026-03-09 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001690585-26-000006 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 131650000 | USD | 2023-03-23 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-23-009331 |
| As of 2022-12-31 | 15365000 | USD | 2024-03-21 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-24-034681 |
| As of 2023-12-31 | 132325000 | USD | 2025-03-11 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-25-037131 |
| As of 2024-12-31 | 22792000 | USD | 2026-03-09 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001690585-26-000006 |
| As of 2025-12-31 | 51087000 | USD | 2026-03-09 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001690585-26-000006 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 7461000 | USD | 2023-03-23 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-23-009331 |
| As of 2022-12-31 | 142000 | USD | 2024-03-21 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-24-034681 |
| As of 2023-12-31 | 185000 | USD | 2025-03-11 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-25-037131 |
| As of 2024-12-31 | 194000 | USD | 2026-03-09 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001690585-26-000006 |
| As of 2025-12-31 | 296000 | USD | 2026-03-09 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001690585-26-000006 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 17262000 | USD | 2023-03-23 | 2022 / FY | us-gaap:Liabilities | 10-K · 0000950170-23-009331 |
| As of 2022-12-31 | 9454000 | USD | 2024-03-21 | 2023 / FY | us-gaap:Liabilities | 10-K · 0000950170-24-034681 |
| As of 2023-12-31 | 10535000 | USD | 2025-03-11 | 2024 / FY | us-gaap:Liabilities | 10-K · 0000950170-25-037131 |
| As of 2024-12-31 | 21531000 | USD | 2026-03-09 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001690585-26-000006 |
| As of 2025-12-31 | 37521000 | USD | 2026-03-09 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001690585-26-000006 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 10863000 | USD | 2023-03-23 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-23-009331 |
| As of 2022-12-31 | 8225000 | USD | 2024-03-21 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-24-034681 |
| As of 2023-12-31 | 9631000 | USD | 2025-03-11 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-25-037131 |
| As of 2024-12-31 | 18452000 | USD | 2026-03-09 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001690585-26-000006 |
| As of 2025-12-31 | 30732000 | USD | 2026-03-09 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001690585-26-000006 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | -17249000 | USD | 2024-03-21 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0000950170-24-034681 |
| As of 2022-12-31 | -44368000 | USD | 2025-03-11 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0000950170-25-037131 |
| As of 2023-12-31 | 168870000 | USD | 2026-03-09 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001690585-26-000006 |
| As of 2024-12-31 | 352477000 | USD | 2026-03-09 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001690585-26-000006 |
| As of 2025-12-31 | 493401000 | USD | 2026-03-09 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001690585-26-000006 |
Revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2023-01-01 to 2023-12-31 | 2826000 | USD | 2025-03-11 | 2024 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0000950170-25-037131 |
| 2024-01-01 to 2024-12-31 | 6235000 | USD | 2026-03-09 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001690585-26-000006 |
| 2025-01-01 to 2025-12-31 | 2036000 | USD | 2026-03-09 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001690585-26-000006 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 46766000 | USD | 2023-03-23 | 2022 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-23-009331 |
| 2022-01-01 to 2022-12-31 | 29379000 | USD | 2024-03-21 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-24-034681 |
| 2023-01-01 to 2023-12-31 | 32841000 | USD | 2025-03-11 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-25-037131 |
| 2024-01-01 to 2024-12-31 | 83105000 | USD | 2026-03-09 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001690585-26-000006 |
| 2025-01-01 to 2025-12-31 | 145638000 | USD | 2026-03-09 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001690585-26-000006 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -74692000 | USD | 2023-03-23 | 2022 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-23-009331 |
| 2022-01-01 to 2022-12-31 | -29705000 | USD | 2024-03-21 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-24-034681 |
| 2023-01-01 to 2023-12-31 | -48174000 | USD | 2025-03-11 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-25-037131 |
| 2024-01-01 to 2024-12-31 | -101864000 | USD | 2026-03-09 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001690585-26-000006 |
| 2025-01-01 to 2025-12-31 | -177933000 | USD | 2026-03-09 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001690585-26-000006 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -71136000 | USD | 2023-03-23 | 2022 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-23-009331 |
| 2022-01-01 to 2022-12-31 | -28476000 | USD | 2024-03-21 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-24-034681 |
| 2023-01-01 to 2023-12-31 | -43555000 | USD | 2025-03-11 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-25-037131 |
| 2024-01-01 to 2024-12-31 | -84969000 | USD | 2026-03-09 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001690585-26-000006 |
| 2025-01-01 to 2025-12-31 | -162337000 | USD | 2026-03-09 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001690585-26-000006 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -1.29 | USD/shares | 2023-03-23 | 2022 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-23-009331 |
| 2022-01-01 to 2022-12-31 | -32.57 | USD/shares | 2024-03-21 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-24-034681 |
| 2023-01-01 to 2023-12-31 | -8.45 | USD/shares | 2025-03-11 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-25-037131 |
| 2024-01-01 to 2024-12-31 | -2.55 | USD/shares | 2026-03-09 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001690585-26-000006 |
| 2025-01-01 to 2025-12-31 | -4.2 | USD/shares | 2026-03-09 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001690585-26-000006 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -59531000 | USD | 2023-03-23 | 2022 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-23-009331 |
| 2022-01-01 to 2022-12-31 | -29070000 | USD | 2024-03-21 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-24-034681 |
| 2023-01-01 to 2023-12-31 | -36861000 | USD | 2025-03-11 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-25-037131 |
| 2024-01-01 to 2024-12-31 | -78180000 | USD | 2026-03-09 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001690585-26-000006 |
| 2025-01-01 to 2025-12-31 | -129060000 | USD | 2026-03-09 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001690585-26-000006 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 1264000 | USD | 2023-03-23 | 2022 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-23-009331 |
| 2022-01-01 to 2022-12-31 | 314000 | USD | 2023-03-23 | 2022 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-23-009331 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1690585
- Ticker in native snapshot
- DNTH
- Reported numeric facts
- 65
- Units present
- USD · USD/shares